Clinical response to imatinib mesylate in recurrent and metastatic gastrointestinal stromal tumors

被引：0
作者：
Villalobos, R. [1 ]
Hernandez, G. [1 ]
Martinez-Prieto, M. [1 ]
Silva, A. [1 ]
机构：
[1] UMAE Hosp Oncol CMN Siglo XXI, Mexico City, DF, Mexico
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
20528
引用
收藏
页数：1
相关论文
共 50 条
[21]   Sprouty4A, a novel genetic marker of response to imatinib mesylate in gastrointestinal stromal tumors (GIST) [J].
Arnoletti, JP ;
Pan, ZZ ;
Fletcher, J ;
Favorova, O ;
Von Mehren, M ;
Eisenberg, BL ;
Godwin, AK .
ANNALS OF SURGICAL ONCOLOGY, 2003, 10 (01) :S8-S8
[22]   IGFBP3 induces apoptosis in gastrointestinal stromal tumors but does not mediate response to imatinib mesylate [J].
Dupart, Jheri ;
Trent, Jonathan ;
Lee, Ho-Young ;
Chiao, Paul ;
Godwin, Andrew ;
Zhang, Wei .
CANCER RESEARCH, 2009, 69
[23]   Gastrointestinal Stromal Tumors Treated with Imatinib Mesylate: Apparent Diffusion Coefficient in the Evaluation of Therapy Response in Patients [J].
Tang, Lei ;
Zhang, Xiao-Peng ;
Sun, Ying-Shi ;
Shen, Lin ;
Li, Jian ;
Qi, Li-Ping ;
Cui, Yong .
RADIOLOGY, 2011, 258 (03) :729-738
[24]   Assessment of gastrointestinal stromal tumors with computed tomography following treatment with imatinib mesylate [J].
Sith Phongkitkarun ;
Cholada Phaisanphrukkun ;
Janjira Jatchavala ;
Ekaphop Sirachainan .
World Journal of Gastroenterology, 2008, (06) :892-898
[25]   Giant Gastrointestinal Stromal Tumor with Remarkable Preoperative Response to Imatinib Mesylate [J].
Stokes, Allen ;
Herndon, Mark D. ;
Conforti, Arnold M. .
AMERICAN SURGEON, 2010, 76 (08) :903-904
[26]   Assessment of gastrointestinal stromal tumors with computed tomography following treatment with imatinib mesylate [J].
Phongkitkarun, Sith ;
Phaisanphrukkun, Cholada ;
Jatchavala, Janjira ;
Sirachainan, Ekaphop .
WORLD JOURNAL OF GASTROENTEROLOGY, 2008, 14 (06) :892-898
[27]   Treatment of localized anorectal gastrointestinal stromal tumors with preoperative imatinib mesylate therapy [J].
Wang, W. ;
Luo, S. ;
Chen, W. ;
Kang, L. ;
Deng, Y. .
EUROPEAN JOURNAL OF CANCER, 2015, 51 :S412-S412
[28]   Imatinib mesylate therapy in patients with gastrointestinal stromal tumors and impaired liver function [J].
Bauer, S ;
Hagen, V ;
Pielken, HJ ;
Bojko, P ;
Seeber, S ;
Schütte, J .
ANTI-CANCER DRUGS, 2002, 13 (08) :847-849
[29]   Imatinib Mesylate: Past Successes and Future Challenges in the Treatment of Gastrointestinal Stromal Tumors [J].
Ksienski, Doran .
CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2011, 5 :365-379
[30]   Gene expression signatures and response to imatinib mesylate in gastrointestinal stromal tumor [J].
Rink, Lori ;
Skorobogatko, Yuliya ;
Kossenkov, Andrew ;
Belinsky, Martin ;
Pajak, Thomas ;
von Mehren, Margaret ;
Ochs, Michael ;
Eisenberg, Burton ;
Godwin, Andrew .
CANCER RESEARCH, 2009, 69
12345